Effect of mild or moderate hepatic impairment on the pharmacokinetics of risdiplam.

Mild or moderate hepatic impairment did not have a clinically relevant impact on the PK of risdiplam. Therefore, no dose adjustment is required in patients with mild or moderate hepatic impairment when receiving risdiplam.